Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailoring the Decision for Adjuvant Chemotherapy Using Circulating Tumour DNA, in Patients With Stage III Colorectal Cancer

NCT07340567 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07340567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07340567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailoring the Decision for Adjuvant Chemotherapy Using Circulating Tumour DNA, in Patients With Stage III Colorectal Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 20, 2026
Completion date
November 1, 2035
Enrollment
2,450 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer